XEME Biopharma Inc. is a clinical-stage company focused on developing therapeutic products in the area of active cancer immunotherapy (vaccines). This area of therapeutic cancer vaccines is expected by many oncology specialists to provide the next breakthrough in the treatment of cancer beyond the current approaches of surgery, radiation, chemotherapy, and passive immunotherapy (monoclonal antibodies).

Biotechnology

XEME Biopharma

Mircea Popescu

Richard Robb

XEME Biopharma's Leadership Team includes Larry Kwak and 2 others.

Leadership Team

About

Team members